Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
NCT01893528
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
REGN2009
OTHER:
placebo
Sponsor
Regeneron Pharmaceuticals